documents: FDA-2013-N-0093-0002
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2013-N-0093-0002 | FDA | FDA-2013-N-0093 | Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Evaluation of the Program for Enhanced Review Transparency and Communication for New Molecular Entity New Drug Applications and Original Biologics License Applications in Prescription Drug User Fee Act | Notice | 30 Day Proposed Information Collection | 2013-05-08T04:00:00Z | 2013 | 5 | 2013-05-08T04:00:00Z | 2015-11-19T19:44:10Z | 2013-10898 | 0 | 0 | 09000064812c4599 |
Links from other tables
- 1 row from regs_document_id in fr_regs_crossref